Durham’s REVIAN shares first study results for novel treatment for type of alopecia
The Durham-based startup REVIAN, a subsidiary of KNOW Bio, has announced results from a study that the company says shows its tech can treat alopecia.
Read More
Know BIO
Durham firm says its light technology can ‘inactivate’ COVID-19 variants
Durham-based EmitBio, which is seeking FDA authorization for use of its light technology to combat COVIDA-19, says its proprietary technology can inactivate variants of the coronavirus that causes COVID-19.
Read More
KNOW Bio: Nitric oxide could help combat coronavirus
While vaccines have dominated the conversation about crushing coronavirus, a local company is working on a potential cure.
Read More
RTP biotech backed by Jim Goodnight says nitric oxide can fight COVID-19
KNOW Bio, a biotech backed by SAS cofounder and CEO Jim Goodnight, says it has demonstrated the “first definitive evidence” that nitric oxide can fight the coronavirus that causes COVID-19.
Read More
Durham startup: Clinical trial results prove it has cure for baldness
REVIAN, formerly known as PhotonMD, says final data from a randomized, double-blind study document the effectiveness of its REVIAN RED hair growth system, which uses LED light to stimulate the body’s cellular generation of nitric oxide and stop hair loss.
Read More
KNOW Bio launches search for 5 execs after landing $30M from Jim Goodnight’s investment firm
KNOW Bio, a spinoff from drug firm Novan, is on the prowl for five senior executives after landing $30 million in investment capital from Reedy Creek Investments, the investment arm of SAS cofounder and CEO Jim Goodnight.
Read More
KNOW Bio incubator forms digestive health subsidiary
KNOW Bio has created a new operating subsidiary to extend that work into gastroenterology. Here’s a look.
Read More
Vast Therapeutics Lands $15M Series A funding, $300K from CF Foundation
Vast Therapeutics is celebrating the new year with Series A funding in excess of $15 million from Shionogi & Co., Ltd. (TYO: 4507) of Japan and a $300,000 award from the Cystic Fibrosis Foundation.
Read More
KNOW Bio raises another $1.1M in equity
Formerly known as Novoclem Therapeutics, Inc., KNOW Bio, is a Research Triangle-based incubator for platform-based medical technology and biotechnology companies.
Read More- 1
- 2
